Alternative Immunomodulatory Strategies for Xenotransplantation: CD40/154 Pathway-sparing Regimens Promote Xenograft Survival

Immunosuppressive therapies that block the CD40/CD154 costimulatory pathway have proven to be uniquely effective in preclinical xenotransplant models. Given the challenges facing clinical translation of CD40/CD154 pathway blockade, we examined the efficacy and tolerability of CD40/CD154 pathway-spar...

Full description

Saved in:

Bibliographic Details
Main Authors:	Thompson, P, Badell, IR, Lowe, M, Turner, A, Cano, J, Avila, J, Azimzadeh, A, Cheng, X, Pierson, R, Johnson, B, Robertson, J, Song, M, Leopardi, F, Strobert, E, Korbutt, G, Rayat, G, Rajotte, R, Larsen, CP, Kirk, AD
Format:	Artigo
Language:	Inglês
Published:	2012
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3387302/ https://ncbi.nlm.nih.gov/pubmed/22458586 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2012.04031.x
Tags:	Add Tag No Tags, Be the first to tag this record!

Alternative Immunomodulatory Strategies for Xenotransplantation: CD40/154 Pathway-sparing Regimens Promote Xenograft Survival

Similar Items